Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ADALIMUMAB (Adalimumab-aacf) and Deucravacitinib (Sotyktu) — clinical data, side effects, and patient experiences.
Adalimumab-aacf, Humira · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Sotyktu · TYK2 Inhibitor
How it works
Selective allosteric inhibitor of tyrosine kinase 2 (TYK2), blocking IL-23, IL-12, and Type I interferon signalling.
Approved for
Estimated frequency (%) based on clinical trial data
No specific warnings
Based on 20 Reddit discussions
ADALIMUMAB
53%
positive
15 threads
Deucravacitinib
40%
positive
5 threads
% of discussions mentioning each side effect
15 Reddit threads analysed for ADALIMUMAB
Overall Sentiment
Mixed
Comparison Threads
9
Avg Post Score
72 upvotes
Most discussed side effects in community
Threads directly comparing ADALIMUMAB to other medications
I am writing this because I am still in shock and honestly struggling to process what happened. I want to know if anyone else with Crohn’s or IBD has experienced something like this and how you dealt with it. I am a 23 year old woman with a severe course of Crohn’s disease affecting the terminal il
31F, 5'6, 145 lbs, white, occasional smoker Humira (adalimumab - for hidradentitis suppurativa) Lamotrigine (mood) Buspirone (anxiety) Vyvanse (ADHD) Let's start off by saying I'm an idiot - when I started taking Humira for my HS a couple years ago I read every about it. I know I am not supposed t
***Disclaimer: This newsflash is for informational purposes. Always consult with your IBD-specialized dietitian or GI team before making significant dietary changes.*** The therapeutic paradigm for ulcerative colitis has shifted fundamentally between 2024 and 2026, transitioning from a reactive
A Quick catch you up on the Rani pill: They have completed a phase one trial of Octreocide in 2019, they still have Phase 2 phase 3 & FDA Approval before commercialization. and have multiple other drug candidates in the background. Capsule dissolves after being swallowed in the small intestine.
**The Scientific History of Adalimumab** Adalimumab is a powerful anti-inflammatory that acts against cytokines, which are protein messengers between cells, that would otherwise encourage inflammation to occur. Adalimumab targets a specific cytokine, TNF, and so we call adalimumab an anti-TNF dr
#Earnings Abbott Laboratories (ABT) Q3 EPS USD 0.75 vs. Exp. USD 0.75, revenue USD 7.7bln vs. Exp. USD 7.65bln. Narrows FY EPS guidance (to USD 2.87-2.89 from 2.85-2.91), but says despite FX headwinds, it is positioned to achieve upper end of its guidance. (Newswires) Cree (CREE) Q1 Adj. EPS US
Hey everyone! I've been on a deep dive into understanding the immune system, particularly in relation to psoriasis. Consolidating information like this really helps me grasp it better. While there's a wealth of knowledge out there, I've highlighted both natural and conventional methods that I've per
Hi all, have had worsening psoriasis and PsA since 2014 and finally today my dermatologist saw me and has put me forward for Adalimumab! I am so happy to finally get approved for a biologic. Fingers crossed it will be the treatment that finally works for me!
Started Skyrizi on Sunday and things are changing. As the old adage goes "Changeable, Curable" I've had one small area of persistent psoriasis clear completely - I'd given it a friction burn from rubbing through clothes on Saturday. On Monday it was red and sore. Tuesday it had dried. Wednesday it p
I’m 23M with psoriasis. I’ve used methotrexate before, then Apremilast for 6 months (stopped working). Now my doctor wants to put me on Tofacitinib, but also asked me to check with insurance about biologics. Shes recommending Ixekizumab (Taltz), but it’s super expensive (₹3–4.5 lakh first year, then
If you'd all humour me while I vent, I'm very much an emotional wreck atm 😅 I've had Plaque Psoriasis since 2012, started on my forehead and then spread to cover my entire face, big patches on my legs, arms, back torso, scalp, ears... You get the drift. After Ciclosporine in 2019 I took a break wit
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
5 Reddit threads analysed for Deucravacitinib
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
6 upvotes
Most discussed side effects in community
NEW YORK — Potential upcoming approvals of JAK inhibitors for hidradenitis suppurativa (HS) and vitiligo suggest these drugs are becoming one of the most versatile therapies in dermatology, and their safety for treating skin diseases might be a story of its own. For dermatologic indications, all JAK
Making this post to gather all the experiences with new medicines (and even traditionals if positive) that are currently being used for various type of scarring alopecias, these being: ***Biological medicines*** 1. **Adalimumab** / Humira 2. **Secukinumab** / Cosentyx 3. **IL-23** / Guselkumab ***Im
Anyone in NYS or anyone working in NYS Independent pharmacies know how to order Sotyktu? I tried ordering through Kinray and it's listed as "Special Order". I called Bristol Myers and they stated Cardinal Health Specialty Distribution are authorized to sell the product. I contacted Kinray (Cardinal
Living with psoriasis was always a daily struggle for me. The constant flare-ups, the unbearable itching, and the visible patches on my skin—psoriasis wasn’t just uncomfortable, it affected my confidence and how I felt about myself. Over the years, I tried countless treatments, from creams to light
This community is dedicated to sharing experiences, insights, and support for those using Deucravacitinib in their journey to manage psoriasis. Whether you’ve been using this supplement for a while, are considering trying it, or just want to learn more, you’re in the right place. # What we’re all ab
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
ADALIMUMAB is a TNF Inhibitor, while Deucravacitinib belongs to the TYK2 Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. ADALIMUMAB is administered via Subcutaneous, whereas Deucravacitinib uses Oral. Route of administration can affect onset of action and patient adherence.
ADALIMUMAB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.